FSA
GILD icon

Fort Sheridan Advisors’s Gilead Sciences GILD Stock Holding History

Fort Sheridan Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$608K Sell
4,810
-20
-0.4% -$2.63K 0.07% 170
2026
Q1 		$673K Sell
4,830
-2,480
-34% -$347K 0.08% 151
2025
Q4 		$897K Hold
7,310
– – 0.11% 116
2025
Q3 		$811K Sell
7,310
-305
-4% -$34.7K 0.11% 121
2025
Q2 		$844K Sell
7,615
-20
-0.3% -$2.13K 0.12% 117
2025
Q1 		$856K Sell
7,635
-65
-0.8% -$6.71K 0.13% 111
2024
Q4 		$711K Sell
7,700
-49
-0.6% -$4.41K 0.1% 128
2024
Q3 		$650K Sell
7,749
-740
-9% -$56.5K 0.1% 130
2024
Q2 		$582K Sell
8,489
-394
-4% -$26.3K 0.09% 132
2024
Q1 		$651K Sell
8,883
-979
-10% -$75.3K 0.12% 112
2023
Q4 		$799K Sell
9,862
-99
-1% -$7.7K 0.16% 95
2023
Q3 		$746K Buy
9,961
+1
+0% +$77 0.17% 94
2023
Q2 		$768K Buy
9,960
+248
+3% +$19.8K 0.18% 87
2023
Q1 		$806K Buy
9,712
+2,638
+37% +$218K 0.2% 84
2022
Q4 		$607K Sell
7,074
-302
-4% -$23.9K 0.2% 91
2022
Q3 		$455K Sell
7,376
-2
-0% -$126 0.15% 106
2022
Q2 		$456K Buy
7,378
+60
+0.8% +$3.71K 0.15% 107
2022
Q1 		$435K Buy
7,318
+188
+3% +$12K 0.13% 109
2021
Q4 		$518K Sell
7,130
-1,655
-19% -$114K 0.15% 107
2021
Q3 		$614K Sell
8,785
-203
-2% -$14.3K 0.2% 89
2021
Q2 		$619K Buy
8,988
+2,495
+38% +$167K 0.21% 88
2021
Q1 		$420K Buy
6,493
+33
+0.5% +$2.13K 0.17% 88
2020
Q4 		$376K Buy
6,460
+200
+3% +$12.1K 0.18% 79
2020
Q3 		$396K Hold
6,260
– – 0.23% 58
2020
Q2 		$482K Sell
6,260
-911
-13% -$69.8K 0.3% 51
2020
Q1 		$536K Buy
7,171
+402
+6% +$27.8K 0.39% 40
2019
Q4 		$440K Buy
6,769
+36
+0.5% +$2.34K 0.24% 63
2019
Q3 		$427K Buy
6,733
+2,292
+52% +$150K 0.24% 55
2019
Q2 		$300K Buy
4,441
+603
+16% +$39.7K 0.17% 69
2019
Q1 		$250K Buy
+3,838
New +$255K 0.16% 68

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fort Sheridan Advisors's GILD Position: Q2 2026 in Review

Fort Sheridan Advisors reduced its Gilead Sciences (GILD) stake by 0.41% in Q2 2026, selling an estimated $2.63K and leaving 4,810 shares worth $608K. The position accounts for 0.07% of the portfolio, ranked #170.

Fort Sheridan Advisors first reported a position in GILD in Q1 2019 and has held it in 30 quarters since. The position peaked at $897K in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fort Sheridan Advisors held 4,810 shares of Gilead Sciences worth $608K as of Q2 2026.
  • Fort Sheridan Advisors sold 20 Gilead Sciences shares in Q2 2026, an estimated $2.63K.
  • Gilead Sciences made up 0.07% of Fort Sheridan Advisors's portfolio in Q2 2026, its #170 holding.
  • Fort Sheridan Advisors first reported a position in Gilead Sciences in Q1 2019 and has held it in 30 quarters since.
  • Fort Sheridan Advisors's Gilead Sciences position peaked at $897K in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fort Sheridan Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.